ATP-Binding Cassette Transporter-2 Regulates Amyloid Precursor Protein Dynamics
ATP 结合盒转运蛋白 2 调节淀粉样蛋白前体蛋白动力学
基本信息
- 批准号:7934484
- 负责人:
- 金额:$ 16.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAlzheimer&aposs disease modelAmyloid beta-Protein PrecursorBrainCellsCholesterolCholesterol HomeostasisCrossbreedingEnzymesEtiologyGenerationsGenesGoalsHomeostasisHumanIn VitroInvestigationKnock-outKnockout MiceKnowledgeLinkLysosomesMediatingMembraneMembrane MicrodomainsMetabolismMicroarray AnalysisMusMutationNeurogliaNeuronsPathway interactionsPeptidesPreventionProcessProductionProtein DynamicsProteinsProteolytic ProcessingRegulationRoleTg2576Transgenic MiceTransgenic OrganismsUrsidae Familyamyloid precursor protein processingbasecholesterol traffickingclinically relevanthuman TAP2 proteinin vivolate endosomemind controlmouse modelmutantnovelpromoterpublic health relevancesecretasetherapeutic development
项目摘要
DESCRIPTION (provided by applicant): Project Summary: The long-term goals of this project focus on establishing the ATP-binding cassette transporter-2 (ABCA2) as a novel regulator of proteolytic processing of the amyloid precursor protein (APR). Amyloidogenic processing of APP results in the generation of A-beta peptide cleavage products that are implicated in the etiology of Alzheimer's disease (AD). The complete elucidation of the mechanisms that regulate APP processing and Ap production has not been realized. One mechanism that regulates APP processing is the cholesterol trafficking-dependent localization of APP and key enzymes that mediate its proteolytic cleavage in membrane compartments. ABCA2 may function to modulate intracellular cholesterol trafficking of exogenous llpoprotein-derived cholesterol from late-endosomes/lysosomes to membrane compartments. We identified ABCA2 as a regulator of APP processing and A-beta production in vitro. We determined that cellular APP holoprotein levels and A-beta secretion were increased in non-neuronal HEK293 cells that stably co-expressed ABCA2 and APP bearing the APP "Swedish" mutation. We also detected increased expression of a number of genes associated with AD using microarray analysis in HEK293 cells that stably expressed ABCA2. Although evidence suggests that ABCA2 may be a key regulator of APP metabolism, perhaps by regulation of intracellular cholesterol trafficking and distribution, we have not examined the effects of ABCA2 function in either neuronal cells or in the brains of transgenic mice expressing mutant forms of APP. Our recent production of ABCA2 knockout mice and ABCA2 transgenic mice under the control of the brain-specific Thy-1 promoter will permit the investigation of this novel function of the ABCA2 transporter in regulating APP processing and A-beta production in vivo in transgenic mouse models of AD. Our preliminary results have led us to the novel hypothesis that ABCA2 acts to regulate APP processing and A-beta production through modulation of intracellular cholesterol trafficking-dependent localization of APP and key processing enzymes in membrane compartments.
Public Health Relevance: These studies may provide novel and mechanistic links between cholesterol metabolism and APP processing that could be of direct clinical relevance. In depth knowledge of the mechanisms of action of the ABCA2 transporter on regulation of APP processing may provide a basis for the development of therapeutic strategies in prevention and treatment of AD.
描述(由申请人提供):项目概述:本项目的长期目标是将ATP结合盒转运蛋白2(ABCA 2)作为淀粉样前体蛋白(APR)蛋白水解加工的新型调节剂。APP的淀粉样蛋白生成加工导致A-β肽裂解产物的产生,所述A-β肽裂解产物与阿尔茨海默病(AD)的病因有关。调节APP加工和Ap生产的机制尚未完全阐明。调节APP加工的一种机制是APP和介导其在膜隔室中的蛋白水解裂解的关键酶的胆固醇运输依赖性定位。ABCA 2可能具有调节外源脂蛋白衍生的胆固醇从晚期内体/溶酶体到膜隔室的细胞内胆固醇运输的功能。我们确定ABCA 2作为APP加工和A-β生产的调节剂在体外。我们确定,在稳定共表达ABCA 2和携带APP“瑞典”突变的APP的非神经元HEK 293细胞中,细胞APP全蛋白水平和A-β分泌增加。我们还使用微阵列分析在稳定表达ABCA 2的HEK 293细胞中检测到许多与AD相关的基因的表达增加。尽管有证据表明ABCA 2可能是APP代谢的关键调节因子,可能通过调节细胞内胆固醇的运输和分布,我们还没有检测ABCA 2功能在神经元细胞或表达APP突变形式的转基因小鼠的脑中的作用。我们最近生产的ABCA 2敲除小鼠和ABCA 2转基因小鼠在脑特异性Thy-1启动子将允许在AD转基因小鼠模型中研究ABCA 2转运蛋白在体内调节APP加工和A-β产生中的这种新功能。我们的初步结果使我们提出了一个新的假设,即ABCA 2通过调节细胞内胆固醇运输依赖性APP和膜室中关键加工酶的定位来调节APP加工和A-β产生。
公共卫生相关性:这些研究可能提供胆固醇代谢和APP加工之间的新的和机制的联系,可能是直接的临床相关性。深入了解ABCA 2转运蛋白调节APP加工的作用机制可能为开发预防和治疗AD的治疗策略提供基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WARREN DAVIS其他文献
WARREN DAVIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WARREN DAVIS', 18)}}的其他基金
ATP-Binding Cassette Transporter-2 Regulates Amyloid Precursor Protein Dynamics
ATP 结合盒转运蛋白 2 调节淀粉样蛋白前体蛋白动力学
- 批准号:
7739032 - 财政年份:2009
- 资助金额:
$ 16.9万 - 项目类别:
ATP-Binding Cassette Transporter-2 Regulates Amyloid Precursor Protein Dynamics
ATP 结合盒转运蛋白 2 调节淀粉样蛋白前体蛋白动力学
- 批准号:
8139674 - 财政年份:2009
- 资助金额:
$ 16.9万 - 项目类别:
ATP-Binding Cassette Transporter-2 Regulates Amyloid Precursor Protein Dynamics
ATP 结合盒转运蛋白 2 调节淀粉样蛋白前体蛋白动力学
- 批准号:
8533026 - 财政年份:2009
- 资助金额:
$ 16.9万 - 项目类别:
ATP-Binding Cassette Transporter-2 Regulates Amyloid Precursor Protein Dynamics
ATP 结合盒转运蛋白 2 调节淀粉样蛋白前体蛋白动力学
- 批准号:
8316298 - 财政年份:2009
- 资助金额:
$ 16.9万 - 项目类别:
ATP-BINDING CASSETTEE TRANSPORTER-2 (ABCA2) REGULATION OF BETA APP PROCESSING
ATP 结合盒转运蛋白 2 (ABCA2) Beta APP 处理的调节
- 批准号:
7959965 - 财政年份:2009
- 资助金额:
$ 16.9万 - 项目类别:
ATP-BINDING CASSETTEE TRANSPORTER-2 (ABCA2) REGULATION OF BETA APP PROCESSING
ATP 结合盒转运蛋白 2 (ABCA2) Beta APP 处理的调节
- 批准号:
7720846 - 财政年份:2008
- 资助金额:
$ 16.9万 - 项目类别:
ATP-BINDING CASSETTEE TRANSPORTER-2 (ABCA2) REGULATION OF BETA APP PROCESSING
ATP 结合盒转运蛋白 2 (ABCA2) Beta APP 处理的调节
- 批准号:
7610450 - 财政年份:2007
- 资助金额:
$ 16.9万 - 项目类别:
ATP-BINDING CASSETTEE TRANSPORTER-2 (ABCA2) REGULATION OF BETA APP PROCESSING
ATP 结合盒转运蛋白 2 (ABCA2) Beta APP 处理的调节
- 批准号:
7381855 - 财政年份:2006
- 资助金额:
$ 16.9万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 16.9万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 16.9万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 16.9万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 16.9万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 16.9万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 16.9万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 16.9万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 16.9万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 16.9万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 16.9万 - 项目类别:














{{item.name}}会员




